Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CARDINAL HEALTH, INC.

(CAH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cardinal Health : UBS Adjusts Cardinal Health's Price Target to $66 From $68, Maintains Buy Rating

05/07/2021 | 10:32am EDT


ę MT Newswires 2021
All news about CARDINAL HEALTH, INC.
06/10CARDINAL HEALTHá : Cancer Test Approved for Use in Children by US FDA
MT
06/09DEA : Companies had 'systematic failure' in monitoring pills
AQ
06/092 MILLION DOSES AND COUNTING : Advocating for our Pharmacists
PU
06/04THERANOSTICS : Reimagining the standard of care
PU
06/03CARDINAL HEALTHá : Oncologists have grown more comfortable with CAR-T therapy, r..
PR
06/01PRIDE MONTH : Stronger Together. Ally for All
PU
06/01CARDINAL HEALTHá : Pending Sale of Cordis Business Receives European Commission'..
MT
06/01STOXX EUROPE 600á : European Commission OKs Hellman and Friedman's Purchase of C..
MT
05/28CARDINAL HEALTHá : New Digital Tool Helps Pharmacies Manage COVID-19 Vaccine Dem..
PU
05/28CARDINAL HEALTHá : and Telix Launch Gallium Awareness Campaign
AQ
More news
Financials (USD)
Sales 2021 160 B - -
Net income 2021 1 051 M - -
Net Debt 2021 3 262 M - -
P/E ratio 2021 16,3x
Yield 2021 3,38%
Capitalization 16 907 M 16 907 M -
EV / Sales 2021 0,13x
EV / Sales 2022 0,12x
Nbr of Employees 48 000
Free-Float 88,8%
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 62,47 $
Last Close Price 58,27 $
Spread / Highest target 21,8%
Spread / Average Target 7,20%
Spread / Lowest Target -3,90%
EPS Revisions
Managers and Directors
NameTitle
Michael C. Kaufmann Chief Executive Officer & Director
Jason M. Hollar Chief Financial Officer
Gregory B. Kenny Independent Non-Executive Chairman
Brian S. Rice Chief Information Officer & Executive VP
Jessica L. Mayer Chief Compliance & Legal Officer
Sector and Competitors
1st jan.Capitalization (M$)
CARDINAL HEALTH, INC.8.91%16 924
WALGREENS BOOTS ALLIANCE, INC.36.48%47 049
JD HEALTH INTERNATIONAL INC.-30.13%44 388
MCKESSON CORPORATION11.70%29 837
HUADONG MEDICINE CO., LTD71.01%13 094
SINOPHARM GROUP CO., LTD.26.99%10 453